Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Company announcement – No. 4 / 2022 Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI) Top-line results expected in the...
-
Company announcement – No. 3 / 2022 Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome Full trial results of EASE-SBS 1...
-
Company announcement – No. 2 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, January 2022 Copenhagen, DK and Boston, MA, January 19, 2022 – Zealand Pharma A/S...
-
Company announcement – No. 1 / 2022 Zealand Pharma to Participate in H.C. Wainwright BIOCONNECT 2022 Conference Copenhagen, DK and Boston, MA, U.S. January 3, 2022 – Zealand Pharma A/S (Nasdaq:...
-
Company announcement – No. 78 / 2021 Total number of shares and voting rights in Zealand Pharma at December 30, 2021 Copenhagen, DK and Boston, MA, December 30, 2021 – Zealand Pharma A/S (“Zealand”)...
-
Company announcement – No. 77 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021 Copenhagen, DK and Boston, MA, December 24, 2021 – Zealand Pharma A/S...
-
Company announcement – No. 76 / 2021 Zealand Pharma Announces Enrollment of Last Patient Needed for Interim Analysis of EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel...
-
Company announcement – No. 75 / 2021 Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital Agreement includes an upfront payment of $100 million in exchange...
-
Company announcement – No. 74 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. December 10, 2021 – Zealand...
-
Company announcement – No. 73 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021 Copenhagen, DK and Boston, MA, November 30, 2021 – Zealand Pharma A/S...